Febuxostat Sandoz 80 mg film-coat. tabl.

Valsts: Beļģija

Valoda: angļu

Klimata pārmaiņas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Nopērc to tagad

Aktīvā sastāvdaļa:

Febuxostat Hemihydrate 82,28 mg - Eq. Febuxostat 80 mg

Pieejams no:

Sandoz SA-NV

ATĶ kods:

M04AA03

SNN (starptautisko nepatentēto nosaukumu):

Febuxostat Hemihydrate

Deva:

80 mg

Zāļu forma:

Film-coated tablet

Kompozīcija:

Febuxostat Hemihydrate 82.28 mg

Ievadīšanas:

Oral use

Ārstniecības joma:

Febuxostat

Produktu pārskats:

CTI code: 514960-06 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-07 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-02 - Pack size: 28 - Commercialisation status: NO - FMD code: 07613421019990 - CNK code: 3906575 - Delivery mode: Medical prescription; CTI code: 514986-05 - Pack size: 84 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-03 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-03 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-05 - Pack size: 84 - Commercialisation status: YES - FMD code: 07613421019983 - CNK code: 3906567 - Delivery mode: Medical prescription; CTI code: 514986-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-07 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-06 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription

Autorizācija statuss:

Commercialised: No

Autorizācija datums:

2017-08-24

Dokumenti citās valodās

Lietošanas instrukcija Lietošanas instrukcija vācu 08-03-2024
Lietošanas instrukcija Lietošanas instrukcija franču 08-03-2024
Produkta apraksts Produkta apraksts franču 08-03-2024
RMP RMP franču 10-11-2022
DHPC DHPC franču 14-12-2022
Lietošanas instrukcija Lietošanas instrukcija holandiešu 08-03-2024
Produkta apraksts Produkta apraksts holandiešu 08-03-2024
RMP RMP holandiešu 10-11-2022
DHPC DHPC holandiešu 14-12-2022

Meklēt brīdinājumus, kas saistīti ar šo produktu